000			03095nam a2200421 c 4500
710	2		_aSpringerLink (Online service) _9106996
999			_c117912 _d117912 _x1
001			117912
003			ES-MaUEC
005			20230102113833.0
006			a||||fo|||| 00| 0
007			cr nn nnnaamaa
008			191111s2019 si a o |||| 0|eng d
020			_a9789813296282
024	7		_a10.1007/978-981-32-9628-2 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRM275 _b2019 EB
245	0	0	_aTherapeutic Vaccines as Novel Immunotherapy : _bBiological and Clinical Concepts _cedited by Hironori Nakagami.
250			_aFirst edition
264		1	_aSingapore _bSpringer International Publishing _c2019
300			_a1 recurso en línea (VII, 79 páginas) _b14 ilustraciones, 9 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_atext file _bPDF
490	0		_aBiomedical and Life Sciences (Springer-11642)
505	0		_aChapter 1.Overview about the concept of therapeutic vaccine -- Chapter 2.Immunotherapy for Tau and amyloid beta against Alzheimer disease -- Chapter 3.Therapeutic vaccine for cardiovascular diseases -- Chapter 4.Immunotherapy for obesity -- Chapter 5.Immunotherapy for spondyloarthritis -- Chapter 6.Recent progress of DNA vaccine -- Chapter 7.Translational research of novel peptide vaccine -- Chapter 8.Conclusion.
520	3		_aThis book offers an excellent introduction to the use of novel therapeutic vaccines for common diseases based on their ability to induce antibody production. While the role of vaccines in the treatment of infectious diseases and cancer is well known, vaccines have also recently been developed for a variety of other conditions, including Alzheimer's disease, hypertension, diabetes, and spondyloarthritis. These therapeutic advances are fully and clearly documented by acknowledged experts in the field, who explain the relevant biology and highlight the challenges involved in deploying this treatment approach effectively and safely. In addition, recent progress in the construction and delivery of DNA vaccines is documented, and the process of developing new peptide vaccines is explored in depth. While the book will be particularly valuable for researchers and scholars interested in immunotherapy, it will also appeal to clinicians seeking effective new medicines to treat patients suffering from chronic diseases.
988			_aPrimersemestre_2020_BiomedLife
650		7	_2embne _aInmunoterapia _9145440
700	1		_aNakagami, Hironori _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9789813296275
776	0	8	_iPrinted edition: _z9789813296299
776	0	8	_iPrinted edition: _z9789813296305
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-32-9628-2 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE _n0
998			_b05/2020 _dz _ea _zSI